Replies to post #2744 on Cellular Biomedicine Group Inc (CBMG)

[Aitkenresearch]

No. I’m not happy with 19.50. I’ve been with this group since Eastbridge.

I’m not so sure everything is a go with Allijon. Which may be the poker tell.
Still a ways off with the Car-t and Immunology for investors and trades. 5 years back when it popped it was bc of another Biotech was bought out traders thought cbmg may be next and Cbmg joined the Nasdaq.
I wonder if Cbmg could be the bridge for other Biotech JV’s in the U.S to get access to China? Sort of like the eastbridge model?